Replies to post #16 on Valneva SE (VALN)

[12yearplan]

Interesting co. p0. Yeah, the two board thing is odd.
And then there's the otc INRLF - odd there with no bid
No board here for that one.

Covid vax getting all the attention but Lyme Disease jab would be sumthin'

https://www.biopharma-reporter.com/Article/2021/03/08/Valneva-and-Pfizer-start-new-Phase-2-study-for-Lyme-disease-vaccine-candidate

https://www.nih.gov/news-events/nih-research-matters/targeted-antibiotic-treating-lyme-disease

Cheers and congrats - nice chart.